Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy outcomes in peritoneal carcinomatosis: 11-year tertiary-center experience
Considering the results in our series, cases of PC in which complete cytoreduction can be achieved should be evaluated for CRS + HIPEC.
Authors
- Cemil Burak Kulle (ORCID: https://orcid.org/0000-0003-2956-4486)
- Neslihan Berker (ORCID: https://orcid.org/0000-0002-0949-7944)
- Celal Caner Ercan (ORCID: https://orcid.org/0000-0003-2922-5847)
- Cemalettın Ertekın (ORCID: https://orcid.org/0000-0002-8052-1628)
- Leman Damla Ercan (ORCID: https://orcid.org/0000-0001-9637-571X)
- Burak Dinçer (ORCID: https://orcid.org/0000-0002-3133-9627)
- Ali Gök (ORCID: https://orcid.org/0000-0002-3203-1253)
- Mehmet İlhan (ORCID: https://orcid.org/0000-0002-6564-5593)
Institutions
- Ministry of Health (TR)
- University of Health Science (KH)
- Sağlık Bilimleri Üniversitesi (TR)
- Istanbul University (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-03-15
- DOI
- https://doi.org/10.1186/s12885-025-13858-x
- Citations
- 2
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 4.01